search
MIRACLE trial
Trends
- 1Moleculin Closes Enrollment in MIRACLE Acute Myeloid Leukemia Trial●Enrollment Closed: What Moleculin’s MIRACLE Trial Teaches About AML Site Execution
Moleculin Biotech has closed enrollment in its MIRACLE trial for acute myeloid leukemia, a step that shifts attention from recruiting patients to follow-up and data collection. Commentary around the milestone is focusing on what the trial's execution across clinical sites reveals about running complex AML studies. Observers in the oncology and biotech community are watching for next results.